Treatment with a PAD4 inhibitor or DNase I overcame neutrophil-dependent chemoresistance, but had no effect on the number of tumor cells in mice not given chemotherapy, while in vitro inhibition of PAD4 improved the efficacy of chemotherapy. This evidence concerns the gene DNASE1 and neoplasm.